Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Novel PEX1 coding mutations and 5' UTR regulatory polymorphisms.
[neonatal adrenoleukodystrophy]
Zellweger
syndrome
and
its
milder
variants--
neonatal
adrenoleukodystrophy
and
infantile
Refsum
disease
--comprise
a
clinical
continuum
of
diseases
referred
to
as
the
Zellweger
spectrum
.
Mutations
in
the
PEX
1
gene
,
which
consists
of
24
exons
and
encodes
a
AAA
ATPase
protein
required
for
peroxisomal
protein
import
,
account
for
approximately
two
-thirds
of
the
known
Zellweger
spectrum
patient
mutations
.
In
this
paper
,
we
report
on
four
novel
PEX
1
mutations
and
two
polymorphisms
in
an
Australasian
cohort
.
Two
of
the
mutations
--c
.
1108
_
1109
insA
and
c
.
2391
_
2392
delTC--that
lead
to
the
introduction
of
a
premature
termination
codon
in
exons
5
and
14
,
respectively
,
are
associated
with
the
severe
Zellweger
phenotype
.
One
patient
with
a
milder
disease
phenotype
was
a
compound
heterozygote
for
two
missense
mutations
(
I
989
T
and
R
998
Q
)
,
both
affecting
amino
acids
in
the
second
,
C-
terminal
AAA
domain
of
the
protein
.
PTS
1
protein
import
levels
in
cultured
skin
fibroblasts
from
this
patient
were
almost
20
%
of
normal
control
levels
.
We
have
also
characterized
two
co
-segregating
polymorphisms
in
the
5
'
UTR
of
the
PEX
1
gene
.
Based
on
reporter
assays
,
the
c
.
-
137
T
>
C
polymorphism
leads
to
reduced
PEX
1
expression
,
whereas
the
c
.
-
53
C
>
G
polymorphism
leads
to
increased
expression
.
When
present
together
,
these
regulatory
polymorphisms
lead
to
near-normal
PEX
1
expression
.
Altered
PEX
1
expression
due
to
the
presence
of
either
the
c
.
-
137
T
>
C
or
the
c
.
-
53
C
>
G
variant
could
impact
on
residual
PEX
1
function
if
another
co
-allelic
mutation
was
present
which
did
not
completely
abolish
PEX
1
function
.
It
also
follows
that
the
presence
of
polymorphisms
in
the
PEX
1
promoter
region
could
have
implications
for
patients
with
mutations
in
other
PEX
proteins
known
to
interact
with
PEX
1
,
such
as
PEX
6
.
Thus
,
although
not
deleterious
in
control
individuals
,
these
polymorphisms
could
contribute
to
phenotypic
heterogeneity
among
Zellweger
spectrum
patients
.
Diseases
Validation
Diseases presenting
"approximately two-thirds"
symptom
neonatal adrenoleukodystrophy
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom